Methodist Le Bonheur expands monoclonal antibody therapies
MEMPHIS, Tenn. (WMC) - Methodist Le Bonheur Healthcare is expanding its monoclonal antibody therapies for COVID-19 patients.
Methodist is the first organization in Tennessee to join this national initiative sponsored by the U.S. Department of Health and Human Services.
The goal is to help end COVID-19 and improve health equity in under-served communities.
There are two infusion locations: Methodist University Hospital and the Methodist Monoclonal Infusion Center on Hacks Cross.
Copyright 2021 WMC. All rights reserved.
Click here to sign up for our newsletter!
Click here to report a spelling or grammar error. Please include the headline.